KRAS and lung carcinoma: Given that verteporfin inhibits cell proliferation in KRAS-mutant lung cancer cells in vitro and in vivo and that the effects of verteporfin through YAP1 inhibition are still controversial, we evaluated whether the inhibitory effect of verteporfin on cell proliferation was truly mediated by YAP1 inhibition.